Lingl, J.P.; Wunderlich, A.; Goerke, S.; Paech, D.; Ladd, M.E.; Liebig, P.; Pala, A.; Kim, S.Y.; Braun, M.; Schmitz, B.L.;
et al. The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T. Diagnostics 2022, 12, 490.
https://doi.org/10.3390/diagnostics12020490
AMA Style
Lingl JP, Wunderlich A, Goerke S, Paech D, Ladd ME, Liebig P, Pala A, Kim SY, Braun M, Schmitz BL,
et al. The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T. Diagnostics. 2022; 12(2):490.
https://doi.org/10.3390/diagnostics12020490
Chicago/Turabian Style
Lingl, Julia P., Arthur Wunderlich, Steffen Goerke, Daniel Paech, Mark E. Ladd, Patrick Liebig, Andrej Pala, Soung Yung Kim, Michael Braun, Bernd L. Schmitz,
and et al. 2022. "The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T" Diagnostics 12, no. 2: 490.
https://doi.org/10.3390/diagnostics12020490
APA Style
Lingl, J. P., Wunderlich, A., Goerke, S., Paech, D., Ladd, M. E., Liebig, P., Pala, A., Kim, S. Y., Braun, M., Schmitz, B. L., Beer, M., & Rosskopf, J.
(2022). The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T. Diagnostics, 12(2), 490.
https://doi.org/10.3390/diagnostics12020490
